These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23932436)

  • 1. Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells.
    Schouppe E; Van Overmeire E; Laoui D; Keirsse J; Van Ginderachter JA
    Immunobiology; 2013 Nov; 218(11):1385-91. PubMed ID: 23932436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
    Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
    Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8
    Drabczyk-Pluta M; Werner T; Hoffmann D; Leng Q; Chen L; Dittmer U; Zelinskyy G
    Retrovirology; 2017 Aug; 14(1):42. PubMed ID: 28835242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
    Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
    J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells in
    Fresno M; Gironès N
    Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells.
    Lim HX; Hong HJ; Cho D; Kim TS
    J Immunol; 2014 Dec; 193(11):5453-60. PubMed ID: 25362180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
    Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
    Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
    Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
    J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
    Youn JI; Nagaraj S; Collazo M; Gabrilovich DI
    J Immunol; 2008 Oct; 181(8):5791-802. PubMed ID: 18832739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells.
    Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
    Curr Protoc; 2022 Oct; 2(10):e557. PubMed ID: 36282094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
    Dean MJ; Ochoa JB; Sanchez-Pino MD; Zabaleta J; Garai J; Del Valle L; Wyczechowska D; Baiamonte LB; Philbrook P; Majumder R; Vander Heide RS; Dunkenberger L; Thylur RP; Nossaman B; Roberts WM; Chapple AG; Wu J; Hicks C; Collins J; Luke B; Johnson R; Koul HK; Rees CA; Morris CR; Garcia-Diaz J; Ochoa AC
    Front Immunol; 2021; 12():695972. PubMed ID: 34341659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8
    Cartwright ANR; Suo S; Badrinath S; Kumar S; Melms J; Luoma A; Bagati A; Saadatpour A; Izar B; Yuan GC; Wucherpfennig KW
    Cancer Immunol Res; 2021 Apr; 9(4):470-485. PubMed ID: 33514509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
    Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
    J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines.
    Chen HW; Chen HY; Wang LT; Wang FH; Fang LW; Lai HY; Chen HH; Lu J; Hung MS; Cheng Y; Chen MY; Liu SJ; Chong P; Lee OK; Hsu SC
    J Immunol; 2013 May; 190(10):5065-77. PubMed ID: 23589610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.